Leadership
The team behind Amanfo AG
MOPhotoMichael Ofori
CEO / Co-founder
MOPhotoMoses Dakerh Ocansey
CTO / Co-founder
AOPhotoAbraham Oben Amoako
Chief Operating Officer
MelDAK Group / Companies / Amanfo AG
Amanfo AG is a Swiss healthcare-technology company. Its flagship platform, BisaRX, connects patients, doctors and pharmacies across Africa — bringing safer, faster, more connected care to millions.
Amanfo AG is a Swiss healthcare-technology company and the digital-health arm of the MelDAK Group — pairing Swiss corporate governance and standards with deep on-the-ground understanding of African healthcare.
Structured as a Swiss holding company, Amanfo AG owns the intellectual property, software and brand behind BisaRX, its digital health platform. Day-to-day services are delivered by a licensed local operating company, BisaRX Ghana Ltd, with further country operations planned across Africa.
Through BisaRX and the OpenPharmacy software, Amanfo builds the digital infrastructure that links patients, doctors and pharmacies — reducing friction, improving safety and widening access to medicine, under a physician- and pharmacist-supervised model.
More than pharmaceutical facilitation — an integrated healthcare infrastructure and data platform for Africa.
BisaRX occupies a rare position between healthcare delivery, healthcare infrastructure and healthcare technology — coordinating the whole ecosystem, not just individual transactions.
BisaRX brings patients, doctors and pharmacies onto a single, trusted network.
Find care, consult doctors, and get prescriptions filled at nearby pharmacies — with medicine, guidance and follow-up all in one place.
Consult patients, issue digital prescriptions, and coordinate with pharmacies through a secure, connected clinical workflow.
Receive verified prescriptions, manage inventory and dispensing, and serve more patients — powered by OpenPharmacy.
OpenPharmacy digitizes how pharmacies operate — the engine that lets BisaRX prescriptions be received, verified and dispensed.
BisaRX follows a deliberate, phased path — proving the core first, then layering on capability responsibly.
AI features are designed to assist — never replace — clinicians. Human oversight remains central at every stage.
In healthcare, trust is the product. BisaRX is designed around meaningful human oversight and strong clinical governance.
Every clinical pathway keeps qualified professionals in the loop. AI assists and informs — it never replaces a clinician's judgement or independently issues prescriptions.
A dedicated medical advisory board and independent clinical oversight committee guide safety, standards and responsible feature rollout.
Clear audit trails, decision logs and escalation procedures make responsibility traceable at every step — treated as core operations, not box-ticking.
A standing compliance committee keeps the platform aligned with evolving healthcare, telemedicine and software regulation across every market.
Health information is among the most sensitive data there is. Data governance is a foundational function at BisaRX — not an afterthought.
The platform is built for multi-jurisdiction compliance and privacy by design, so patients, clinicians and partners can trust how information is collected, stored and used.
Centralised ownership in Switzerland; locally licensed operations in each market.
Owns 100% of the BisaRX intellectual property, software and brand; provides governance, strategy and capital.
Runs day-to-day operations, regulatory compliance, and pharmacy & physician onboarding in Ghana.
Future locally-licensed operations planned for Kenya, South Africa, Nigeria and beyond.
MOPhotoMOPhotoAOPhotoAmanfo AG anchors the group's healthcare technology in Switzerland, developing BisaRX and OpenPharmacy alongside MelDAK Technologies.